Abbreviated New Drug Application

Exactly right.

And very briefly, when a brand manufacturer creates a new med, they submit something called a new drug application or an NDA to the FDA after completing, obviously, clinical trials to prove the drug's safety and effectiveness, which we're all used to, right? Now, generic manufacturers can submit an abbreviated new drug application or ANDA to to market their drug after the brand's patent expires.

And it's abbreviated because the generic company doesn't need to repeat all those costly safety and effectiveness studies, although they do need to prove that the med is absorbed to the same rate and extent.

Well, lucky them.

Correct.

And traditional generics can have different enacting ingredients like things like binders and fillers and dyes.

And going back to what you said about NDAs from the legal side, authorized generics are sold under the brand products existing NDA, not a separate ANDA like we talked about with traditional generics.

Good point.

well? So we don't actively do that.

What I believe you're referring to is an ANDA.

So it's an abbreviated new drug application where we'd be able to help either a brand of manufacturer or big pharma kind of create that drug for trials.

We are not involved in that currently, but there's definitely manufacturers that do aid in that.